Chadi Nabhan on Muck Rack

Chadi Nabhan

Chicago
As seen in: Apple Podcasts, Wiley Online Library, The Oncologist, JAMA (The Journal of the American Medical Association), JAMA Oncology, JAMA: Journal of the American Medical Association, Medscape, STAT, The Health Care Blog (THCB), Future Medicine and
Heme/Onc; NHL/HL/CLL. Adj Professor U of SC; Host: the #HealthcareUnfiltered podcast. Author of "TOXIC EXPOSURE" & “THE CANCER JOURNEY.” 3rd book out in 2026.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chadi

Contact Chadi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Cigarette

|
By Chadi Nabhan
| JAMA Oncology Verified
I was at his wife’s funeral when she died 3 years ago. I recall when he shared the news of her breast cancer recurrence with me and how devastating this was on the entire family. He was a smoker, and he started smoking more often after her death. Frequently, I would see him with a cigarette in his hand.
Open in Who Shared Issue with article?

What We Wish We Knew During Fellowship

|
By Chadi Nabhan, Jasmine Kamboj, Noha Soror
| The ASCO Post Verified
July marks a significant transition for many professionals, particularly those beginning structured training programs on July 1. This article is designed to support new and current hematology-oncology fellows and trainees in making the most of their training experience. Although not all suggestions provided will apply universally, the tips offered here are meant to be adapted and personalized to fit your unique circumstances and program.
Open in Who Shared Issue with article?

The Inflation Reduction Act and Etanercept

|
By Charles Bennett, Jason Gibbons, Chadi Nabhan, Kenneth R. Carson
| Wiley Online Library Verified
In August, the Centers for Medicare and Medicaid Services (CMS) announced a negotiated price 67% lower than the manufacturer list price for etanercept (Enbrel; Amgen). This price will go into effect in January 2026. Negotiations with the manufacturer began following passage of the Inflation Reduction Act (IRA) that allows CMS to negotiate prices for up to 20 drugs in 2025.1 Etanercept was one of the first 10 drugs included for negotiation for Medicare Part D.
Open in Who Shared Issue with article?
See all 75 licensed articles (80 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified